Non-alcoholic steatohepatitis: a microbiota-driven disease

AR Moschen, S Kaser, H Tilg - Trends in Endocrinology & Metabolism, 2013 - cell.com
Non-alcoholic fatty liver disease (NAFLD) has emerged as a major health problem
worldwide. Whereas overnutrition and obesity are crucially involved in the development of a …

Links between gut microbiome, metabolome, clinical variables and non‐alcoholic fatty liver disease severity in bariatric patients

KJP Schwenger, D Sharma, Y Ghorbani… - Liver …, 2024 - Wiley Online Library
Abstract Background and Aims Bacterial species and microbial pathways along with
metabolites and clinical parameters may interact to contribute to non‐alcoholic fatty liver …

[HTML][HTML] Dietary approach in the treatment of nonalcoholic fatty liver disease

SM Ferolla, LC Silva, MLA Ferrari… - World Journal of …, 2015 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) has been identified as one of the most prevalent
chronic liver disease in adults and children populations. NAFLD is usually associated with …

Systematic review and meta-analysis: the role of diet in the development of nonalcoholic fatty liver disease

E Tsompanaki, K Thanapirom, M Papatheodoridi… - Clinical …, 2023 - Elsevier
Background & Aims The association of nonalcoholic fatty liver disease (NAFLD) with dietary
factors is well established but not thoroughly investigated. This systematic review and meta …

Role of the gut microbiome in nonalcoholic fatty liver disease

B Aqel, JK DiBaise - Nutrition in clinical practice, 2015 - Wiley Online Library
The incidence of nonalcoholic fatty liver disease (NAFLD) continues to increase with
prevalence estimates ranging from 17%–33%, making it is the most common cause of …

Nonalcoholic steatohepatitis and the intestinal microbiota

DB Haslam - Hepatology, 2017 - journals.lww.com
Nonalcoholic steatohepatitis (NASH), charac-terized by fatty infiltration of the liver,
hepatocellular injury, and hepatic inflammation, is a major cause of liver failure. The …

Gut microbiota in nonalcoholic fatty liver diseases with and without type-2 diabetes mellitus

HE Leylabadlo, HS Kafil, S Farajnia… - European Journal of …, 2021 - journals.lww.com
Results NAFLD patients with T2DM had significantly higher BMI, triglyceride level, and total
cholesterol level were compared with controls (Pv< 0.05). Bacteroidetes and Firmicutes …

[PDF][PDF] What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. Metabolites 2023, 13, 378

S Jarmakiewicz-Czaja, J Gruszecka, R Filip - 2023 - researchgate.net
Liver disease is one of the most common extraintestinal manifestations of inflammatory
bowel disease (IBD). Often the course of liver disease is associated with an exacerbation of …

[引用][C] Sa1629–the risk factors and prevalence of non-alcoholic fatty liver disease in inflammatory bowel disease

A Lee, V Shah, N Nandi - Gastroenterology, 2019 - Elsevier

Non-alcoholic fatty liver disease: an update with special focus on the role of gut microbiota

M Doulberis, G Kotronis, D Gialamprinou, J Kountouras… - Metabolism, 2017 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is a significant global health burden in children,
adolescents and adults with substantial rise in prevalence over the last decades …